Susan Beach
Advertisement
Vice President - Commercial Solutions, Diligent Health Solutions
Articles by Susan Beach
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on PharmExec
1
Roundup: Gilead Acquires Oral IL-23R Inhibitor From PepStar for $1.275 Billion, Zymeworks Licenses DLL3-Targeting T Cell Engager to Roche
2
Treasury Proposes Rules Adding Biotechnology to Outbound Investment Security Program
3
FDA Approves Subcutaneous Induction for Skyrizi in Crohn's Disease
4
MFN Is an Offer Pharma Can’t Refuse
5